26,855€
-0,15%
Echtzeit-Aktienkurs DAIICHI SANKYO CO. LTD
Bid:
Ask:
Echtzeit-Chart der DAIICHI SANKYO CO. LTD Aktie
Börsenkurse DAIICHI SANKYO CO. LTD
Börse Frankfurt | - | - | - | - | 26,795€ | 1,08% |
Echtzeit Euro | - | - | - | - | 26,865€ | -13,31% |
gettex | - | - | - | - | 26,825€ | -0,24% |
Tradegate | - | - | - | - | 26,820€ | -1,07% |
Börse Stuttgart | - | - | - | - | 26,600€ | -1,85% |
Lang & Schwarz | - | - | - | - | 26,855€ | -0,15% |
Profil der DAIICHI SANKYO CO. LTD Aktie
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.